This session is organized by GLOBE – Global Life Sciences Opportunities Business Exchange, an Intellectual Exchange Group with the North Carolina Biotechnology Center. GLOBE partners include the U.S.

Only five days after FDA approval of Yutrepia, Liquidia announced its first commercial shipment of the therapy, making prescriptions available to patients at specialty pharmacies. “We have moved with ...

Califf completed his second term as FDA commissioner in January with the change in administrations. He’s only the second ...

In an all-digital world, how can a more hands-on, personalized marketing and sales approach be leveraged to strengthen human connections? Come to this talk and discover how a personal touch can take ...

The North Carolina Biotechnology Center awarded eight grants and loans totaling more than $1.2 million to universities and life sciences companies in the second quarter of its current fiscal year.

Today marks International Women’s Day: a day devoted to celebrating women, their achievements and recognizing the bias that holds many back. Women in the Workplace 2020, a national report conducted by ...

The U.S. Food and Drug Administration (FDA) has accepted Durham-based BioCryst Pharmaceuticals’ application to expand the use of ORLADEYO (berotralstat) to treat children ages 2 to 11 with a rare ...

Procter & Gamble Co. (P&G), the world’s largest maker of packaged consumer goods, will invest $110 million and create 46 jobs as it expands its manufacturing plant in Greensboro. “We are excited to ...

Enzyvant Therapeutics, Inc. and Altavant Sciences, Inc., both wholly owned subsidiaries of the global biopharmaceutical giant Sumitovant Biopharma Ltd., today announced a merger to form a North ...

There’s strength in numbers in the global pharmaceutical marketplace, so a small Durham pharmaceutical company is adding numbers to launch its novel prescription drug that won federal marketing ...